Analyst Ratings For Mediclinic International PLC (LON:MDC)
Today, Credit Suisse Group reiterated its Neutral rating on Mediclinic International PLC (LON:MDC).
There are 2 sell ratings, 6 hold ratings on the stock.
The current consensus rating on Mediclinic International PLC (LON:MDC) is Hold (Score: 1.75) with a consensus target price of GBX 823.13 per share, a potential .
Some recent analyst ratings include
- 7/21/2017-Credit Suisse Group Reiterated Rating of Neutral.
- 6/29/2017-Morgan Stanley was Downgraded by analysts at Morgan Stanley from a “Equal Weight” rating to a “” rating. They now have a GBX 775 price target on the stock, up previously from GBX 825 .
- 6/27/2017-Citigroup Inc. Reiterated Rating of Neutral.
- 6/26/2017-Investec was Downgraded by analysts at Investec from a “Hold” rating to a “” rating. They now have a GBX 775 price target on the stock.
Recent Trading Activity for Mediclinic International PLC (LON:MDC)
Shares of Mediclinic International PLC closed the previous trading session at 740.00 up +0.21 0.03% with 1,113,804 shares trading hands.
